Search

everythinglearnresearchcommunity

for

Search:↓

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Enhancing Tregs can protect against alopecia areata.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

A rare skin condition linked to leukemia improved with chemotherapy.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

SLE affects lungs and kidneys similarly due to immune complexes.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Zinc may help treat alopecia areata by boosting certain immune cells.